Wissam Ghusn
Appearances
- DateMay 20, 2024BACKGROUND: Our phenotype-guided approach to antiobesity medications is associated with greater weight loss compared to the obesity medicine standard of care…
Presenter
Speakers
Mayo Foundation for Medical Education and Research - DateMay 18, 2024BACKGROUND: Obesity is considered a major risk factor for developing multiple complications and medical conditions including type-2 diabetes mellitus (T2DM). Multiple scores (i.e., Individualized Metabolic Surgery [IMS], DiaRem, advanced DiaRem, and Robert et Al…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Foundation for Medical Education and Research - DateMay 20, 2024Obesity and type-2 diabetes mellitus (T2DM) are two inter-related chronic diseases with significant medical and financial burden. T2DM results in detrimental vascular complications including microvascular and macrovascular diseases…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Foundation for Medical Education and Research